TCWM
CRVS icon

Total Clarity Wealth Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Total Clarity Wealth Management’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed – – 363
2022
Q2 		$0 Buy
+500
New +$613 ﹤0.01% 1020
2022
Q1 		– Sell
-500
Closed -$1K – 349
2021
Q4 		$1K Sell
500
-2,000
-80% -$7.76K ﹤0.01% 948
2021
Q3 		$12K Buy
+2,500
New +$7.4K 0.01% 628

Other funds holding CRVS

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return